SCHAUMBURG, Ill., Dec. 15 The American Academy ofDermatology (Academy) today issued a statement in response to the Food andDrug Administration's Report to Congress about labeling information on therelationship between the use of indoor tanning devices and development of skincancer or other skin damage. The FDA report was submitted pursuant to Section230 of the Food and Drug Administration Amendments Act of 2007.
"The American Academy of Dermatology is pleased that the Food and DrugAdministration (FDA) has taken a closer look at the warning label on indoortanning beds as required by the Tanning Accountability and Notification Act of2007 (TAN Act)," said dermatologist C. William Hanke, MD, MPH, FAAD, presidentof the American Academy of Dermatology. "Tanning bed use is known tocontribute to the development of skin cancer, especially among young adults.The Academy aims to lead the charge to reduce the incidence of and mortalityfrom skin cancer by raising awareness about the dangers of indoor tanningequipment use and promoting stricter regulation of indoor tanning facilities,particularly restricting access by children under 18.
"The FDA's review of the tanning bed label and its subsequent report toCongress, as well as the FDA's public Web site outlining the consequences ofindoor tanning, are helpful in raising awareness about the dangers of tanning.However, based on published research studies, the Academy strongly believesthat a warning label on the tanning equipment simply is not enough toinfluence an individual's decision to forego tanning. We hope that the TANAct is a first step that will lead to more impactful legislation andregulation at the state and federal levels, which will restrict access toindoor tanning facilities for at least minors, and ultimately significantlyreduce the incidence of skin cancer," Dr. Hanke said.
For more information about skin cancer, please visit the SkinCancerNetsection on http://www.skincarephysicians.com, a Web site developed bydermatologists that provides the public with up-to-date information on thetreatment and management of disorders of the skin, hair and nails.
Headquartered in Schaumburg, Ill., the American Academy of Dermatology(Academy), founded in 1938, is the largest, most influential, and mostrepresentative of all dermatologic associations. A sister organization to theAcademy, the American Academy of Dermatology Association is the resource forgovernment affairs, health policy and practice information for dermatologists,and plays a major role in formulating policies that can enhance the quality ofdermatologic care. With a membership of more than 15,000 physiciansworldwide, the Academy is committed to: advancing the diagnosis and medical,surgical and cosmetic treatment of the skin, hair and nails; advocating highstandards in clinical practice, education, and research in dermatology; andsupporting and enhancing patient care for a lifetime of healthier skin, hairand nails. For more information, contact the Academy at 1-888-462-DERM (3376)or http://www.aad.org.
SOURCE American Academy of Dermatology